SCHEMBL14083374

SCHEMBL14083374

CCN(CC)c1ccc(NC(=O)c2ccc(-c3ncccc3OC)c(Cl)c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.53
▸ ALDH1A1 P00352 4/20 0.53
▸ NPSR1 Q6W5P4 2/20 0.53
▸ HTT P42858 2/20 0.53
▸ GAA P10253 1/20 0.53
▸ KMT2A Q03164 4/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ LMNA P02545 2/20 0.51
▸ MAPK1 P28482 2/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ GFER P55789 1/20 0.49
▸ GHSR Q92847 3/20 0.48
▸ AURKB Q96GD4 1/20 0.48
▸ MCL1 Q07820 1/20 0.45
▸ THRB P10828 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ HPGD P15428 1/20 0.45
▸ PPARG P37231 1/20 0.45
▸ RXFP1 Q9HBX9 1/20 0.45
▸ NCOR2 Q9Y618 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083298 0.92 GHSR (0.54) MAPTALDH1A1NPSR1HTTGAA
SCHEMBL14083771 0.89 ALDH1A1 (0.54) MAPTALDH1A1NPSR1HTTGAA
SCHEMBL14083094 0.89 MAPT (0.49) MAPTALDH1A1NPSR1HTTGAA
SCHEMBL14083379 0.88 TRPV1 (0.55) MAPTKMT2AMEN1AURKBTHRB
SCHEMBL14083377 0.87 AURKB (0.54) MAPTALDH1A1HTTGAAKMT2A
SCHEMBL14083401 0.86 TP53 (0.52) MAPTALDH1A1NPSR1KMT2AMEN1
SCHEMBL14083384 0.85 TRPV1 (0.55) MAPTKMT2AMEN1AURKBTHRB
SCHEMBL14083380 0.85 GRM4 (0.61) MAPTALDH1A1KMT2AMEN1LMNA
SCHEMBL14083385 0.85 TRPV1 (0.48) MAPTALDH1A1LMNAAURKBKDM4E
SCHEMBL14083383 0.84 TRPV1 (0.62) MAPTSMN1; SMN2TP53TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 MAPT 2822/4885ALDH1A1 1577/4885NPSR1 406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback